Effect of Micromixer Design on Lipid Nanocarriers Manufacturing for the Delivery of Proteins and Nucleic Acids.

lipid nanocarriers lipid nanoparticles liposomes manufacture microfluidics nucleic acids proteins

Journal

Pharmaceutics
ISSN: 1999-4923
Titre abrégé: Pharmaceutics
Pays: Switzerland
ID NLM: 101534003

Informations de publication

Date de publication:
07 Apr 2024
Historique:
received: 11 03 2024
revised: 01 04 2024
accepted: 02 04 2024
medline: 27 4 2024
pubmed: 27 4 2024
entrez: 27 4 2024
Statut: epublish

Résumé

Lipid-based nanocarriers have emerged as helpful tools to deliver sensible biomolecules such as proteins and oligonucleotides. To have a fast and robust microfluidic-based nanoparticle synthesis method, the setup of versatile equipment should allow for the rapid transfer to scale cost-effectively while ensuring tunable, precise and reproducible nanoparticle attributes. The present work aims to assess the effect of different micromixer geometries on the manufacturing of lipid nanocarriers taking into account the influence on the mixing efficiency by changing the fluid-fluid interface and indeed the mass transfer. Since the geometry of the adopted micromixer varies from those already published, a Design of Experiment (DoE) was necessary to identify the operating (total flow, flow rate ratio) and formulation (lipid concentration, lipid molar ratios) parameters affecting the nanocarrier quality. The suitable application of the platform was investigated by producing neutral, stealth and cationic liposomes, using DaunoXome

Identifiants

pubmed: 38675169
pii: pharmaceutics16040507
doi: 10.3390/pharmaceutics16040507
pii:
doi:

Types de publication

Journal Article

Langues

eng

Subventions

Organisme : Regional Operational Programe of the European Regional Development Fund - POR FESR 2014-2020 program - through the project "DSF (Digital Smart Fluidics): Fluidica Digitale per le Scienze della Vita"
ID : 1175234
Organisme : Piano Operativo Salute, F13C22001110001 Traiettoria 4 (T4-CN-02) - Interventi per la creazione di Hub delle Scienze della Vita nei settori della Farmaceutica, del Biomedicale e delle Biotecnologie - Immuno-HUB (Immunoterapia: cura e prevenzione di malatti
ID : F13C22001110001

Auteurs

Enrica Chiesa (E)

Department of Drug Sciences, University of Pavia, V.le Taramelli 12, 27100 Pavia, Italy.

Alessandro Caimi (A)

Department of Civil Engineering and Architecture, University of Pavia, Via Ferrata 3, 27100 Pavia, Italy.

Marco Bellotti (M)

Department of Civil Engineering and Architecture, University of Pavia, Via Ferrata 3, 27100 Pavia, Italy.

Alessia Giglio (A)

Department of Drug Sciences, University of Pavia, V.le Taramelli 12, 27100 Pavia, Italy.

Bice Conti (B)

Department of Drug Sciences, University of Pavia, V.le Taramelli 12, 27100 Pavia, Italy.

Rossella Dorati (R)

Department of Drug Sciences, University of Pavia, V.le Taramelli 12, 27100 Pavia, Italy.

Ferdinando Auricchio (F)

Department of Civil Engineering and Architecture, University of Pavia, Via Ferrata 3, 27100 Pavia, Italy.

Ida Genta (I)

Department of Drug Sciences, University of Pavia, V.le Taramelli 12, 27100 Pavia, Italy.

Classifications MeSH